Cantitate/Preț
Produs

Intraocular Drug Delivery

Editat de Glenn J. Jaffe, Paul Ashton, P. Andrew Pearson
en Limba Engleză Paperback – 11 noi 2019
This reference studies the most recent advances in the development of ocular drug delivery systems. Covering methods to treat or prevent ocular inflammation, retinal vascular disease, retinal degeneration, and proliferative eye disease, this source covers breakthroughs in the management of endophthalmitis, uveitis, diabetic macular edema, and age-related macular degeneration.
Citește tot Restrânge

Preț: 36342 lei

Preț vechi: 46481 lei
-22% Nou

Puncte Express: 545

Preț estimativ în valută:
6955 7234$ 5742£

Carte tipărită la comandă

Livrare economică 14-28 aprilie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780367453817
ISBN-10: 0367453819
Pagini: 384
Dimensiuni: 178 x 254 mm
Greutate: 0.71 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press

Cuprins

GENERAL. Retinal Drug Delivery. Blood Retinal Barrier. Neuroprotection. Regulatory Issues in Drug Delivery to the Eye. SPECIFIC DELIVERY SYSTEMS. Intravitreal Injection. Anti-angiogenic Agents. Intravitreal Antimicrobials. Pharmacologic Retinal Reattachment with INS37217 (Denufosol Tetrasodium), a Nucleotide P2Y2 Receptor Agonist. Cell Based Delivery Systems. Photodynamic Therapy. Thermal Sensitive Liposomes. Gene Therapy for Retinal Disease. Biodegradable Systems. Transscleral Drug Delivery to the Retina and Choroid. Nondegradable Intraocular Sustained Release Drug Delivery Devices. LOCAL DRUG DELIVERY APPROACH TO SPECIFIC CLINICAL DISEASES. Age-Related Macular Degeneration. Photodynamic Therapy Human Clinical Studies. Age-Related Macular Degeneration Drug Delivery. Intraocular Sustained Drug Delivery in Uveitis. Drug Delivery for Proliferative Vitreoretinopathy: Prevention and Treatment. Pharmacological Treatment in Diabetic Macular Edema. Retinal Vein Occlusion. Cytomegalovirus (CMV) Retinitis. Endophthalmitis


Notă biografică

Glenn J. Jaffe Paul Ashton P. Andrew Pearson

Descriere

This reference studies the most recent advances in the development of ocular drug delivery systems. Covering methods to treat or prevent ocular inflammation, retinal vascular disease, retinal degeneration, and proliferative eye disease, this source covers breakthroughs in the management of endophthalmitis, uveitis, diabetic macular edema, and age-r